| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |